Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived— vs Q4 2019 Net Income-$1.33M-$1.33MderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,156,523N/M Operating Cash Flowderived-$308,690N/M ended Jul 31, 2020 · filed Nov 16, 2020 · 108 d after period end